Academic History

Jonathan Rosenberg, MD, is Doctor of Medical Oncology, the Chief of the Genitourinary Oncology Service and the Enno W. Ercklentz Jr. Chair at Memorial Sloan Cancer Center, New York, NY.

Dr Rosenberg received his undergraduate degree from Duke University, Durham, NC, completed his MD at Harvard Medical School in Boston, MA, his residency at New York Presbyterian/Weill Cornell Medical Center in New York and his fellowship in Medical Oncology at the University of California San Francisco Medical Center, San Francisco, CA.

Speaking on bladder, ureter, and urachal cancer

Dr Rosenberg’s research focuses on understanding the underlying bladder cancer biology with the objective of developing new therapies to treat bladder cancer. He aims to identify novel genetic biomarkers and connecting these to clinical outcomes in bladder cancer. Dr Rosenberg has previously investigated the use of enfortumab vedotin as a therapy for urothelial cancer.